Skip to main content
. Author manuscript; available in PMC: 2020 Dec 11.
Published in final edited form as: Clin Infect Dis. 2009 Jun 15;48(12):1639–46. doi: 10.1086/599031

Table 4. Patients with influenza A (H5N1) infection who received treatment with granulocyte macrophage colony-stimulating factor (GMCSF).

Day after hospital admission
Patient, variable 1 2 3 4 5 6 7 8 9 10
1: male, aged 1 year
      Received GMCSF 0.5 MIU/kg Yes Yes Yes
      Neutrophil count, cells/mm3 406 1705 2520 6720
      Platelet count, platelets/mm3 31,000 95,000 38,000 58,000
      Death Died
2: female, aged 8 years
      ReceivedGMCSF0.5MIU/kg Yes
      Neutrophil count, cells/mm3 290 798 15,040
      Platelet count, platelets/mm3 81,000 162,000 269,000
      Death Died
3: female, aged 10 years
      Received GMCSF 0.5 MIU/kg Yes
      Neutrophil count, cells/mm3 1904 1421 2701 2448 5395 21,760
      Platelet count, platelets/mm3 13,500 143,000 144,000 130,000 151,000 245,000
      Death Died
4: male, aged 4 years
      Received GMCSF 0.5 MIU/kg Yes Yes Yes
      Neutrophil count, cells/mm3 1081 476 1976 7344 9040
      Platelet count, platelets/mm3 15,000 200,000 79,000 121,000 344,000
      Death Died
5: female, aged 1 year
      ReceivedGMCSF1MIU/kg Yes
      Neutrophil count, cells/mm3 300
      Platelet count, platelets/mm3 31,000
      Death Died
6: male, aged 4 years
      Received GMCSF 0.5 MIU/kg Yes
      Neutrophil count, cells/mm3 1748 576 6060 4600
      Platelet count, platelets/mm3 73,000 59,000 242,000 353,000 376,000
      Death